Nathan Tucker (Instructor in Medicine, Massachusetts General Hospital and Project Team Lead, Precision Cardiology Laboratory, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Boston, MA, USA) speaks to us about the topic of his presentation ‘Late-Breaking Basic Science: An Atlas of Transcriptional Diversity in the Human Heart: Analysis of 287,269 Single Cell Transcriptomes From the Four Chambers of the Non-Failing Heart’, presented at the American Heart Association (AHA) Scientific Sessions 2019.
Speaker’s Disclosures: Dr. Tucker has significant research grant from Bayer AG, and from the NHLBI (federal funding).
1. Please tell us about the topic of your presentation? (0:05)
2. What is the next step for this research? (3:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the substudy of the FAME 3 trial and the implications for clinical practice. […]
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part […]
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!